![Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections - Smith - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections - Smith - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library](https://accpjournals.onlinelibrary.wiley.com/cms/asset/e23745bd-ab64-42e5-93c7-efda6abf3a4e/phar2378-fig-0001-m.jpg)
Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections - Smith - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library
![Antibiotics | Free Full-Text | Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy Antibiotics | Free Full-Text | Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy](https://www.mdpi.com/antibiotics/antibiotics-10-01184/article_deploy/html/images/antibiotics-10-01184-g001.png)